Why the study?
Understanding the impact of early vascular aging on acute ischemic stroke outcomes was sought to validate the early vascular aging ambulatory score and assess its association with stroke type, severity, and prognosis.
Does the early vascular aging ambulatory score (EVAAs) predict poor outcomes in patients with acute ischemic stroke?
Does the early vascular aging ambulatory score (EVAAs) predict poor outcomes in patients with acute ischemic stroke?
The early vascular aging ambulatory score (EVAAs) is a significant independent predictor of adverse outcomes at discharge and 90 days in patients with acute ischemic stroke, particularly those with lower cardiovascular disease burden.
Answers are grounded in this paper and cite their sources.
Should not yet guide acute ischemic stroke care; leaves open prospective validation of EVAAs for risk stratification.
Understanding the impact of early vascular aging (EVA) on acute ischemic stroke (AIS) outcomes may provide new insights for improving prognostic assessments and developing targeted therapeutic strategies. This study aimed to validate the EVA ambulatory score (EVAAs) in AIS patients, assessing its association with stroke type, severity, and prognosis. Among the 2,730 AIS patients with a mean age of 72.0 ± 14.4 years, 83.4% exhibited EVA. EVA was identified as an independent predictor of poor outcome at both discharges (aOR:1.72, 95%CI:1.25-2.36, p < 0.001) and at 90 days (aOR:2.22, 95%CI:1.49-3.31, p < 0.001). In subgroup analyses, EVAAs showed improved predictive value in AIS patients with a lower cardiovascular disease burden and a non-atherogenic lipid profile. The EVAAs, as an indicator of EVA that could be easily integrated into daily clinical practice, are a significant predictor of adverse outcomes in AIS patients.
No takes yet. Share an insight, caveat, or question.
Kakaletsis et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: